Skip to main
KMB
KMB logo

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 9%
Buy 18%
Hold 64%
Sell 0%
Strong Sell 9%

Bulls say

Kimberly-Clark is a dominant force in the tissue and hygiene market, with over 50% of its sales derived from personal care products and approximately one-third from consumer tissue goods. The company is actively enhancing its innovation pipeline, which is expected to be more robust in 2026, allowing it to leverage new technologies across its product offerings. Additionally, Kimberly-Clark plans to integrate Kenvue's consumer health portfolio into its operations by the second half of 2026, potentially expanding its market reach and enhancing revenue streams.

Bears say

Kimberly-Clark has experienced a significant downward revision of its 3Q25 North America organic sales growth estimate, shifting from a prior increase of 4.5% to a decline of 4.0%. Additionally, trends indicate a troubling -2.7% decline in US measured retail sales for the third quarter of 2025. Furthermore, earnings per share (EPS) projections have been decreased, with the fiscal 2025 estimate reduced from $7.60 to $7.41, and the 2026 EPS forecast lowered from $8.00 to $7.85.

Kimberly-Clark (KMB) has been analyzed by 11 analysts, with a consensus rating of Hold. 9% of analysts recommend a Strong Buy, 18% recommend Buy, 64% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 11 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $127.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $127.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.